MARKET

TARA

TARA

ArTara Therapeutics
NASDAQ

Real-time Quotes | Nasdaq Last Sale

28.50
-0.42
-1.45%
Closed 16:00 02/28 EST
OPEN
26.00
PREV CLOSE
28.92
HIGH
29.02
LOW
26.00
VOLUME
17.43K
TURNOVER
--
52 WEEK HIGH
157.60
52 WEEK LOW
8.80
MARKET CAP
166.53M
P/E (TTM)
-0.0185
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of TARA and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 1 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average TARA stock price target is 1.000 with a high estimate of 1.000 and a low estimate of 1.000.

EPS

TARA News

More
  • ArTara Therapeutics Appoints Blaine Davis Chief Financial Officer
  • Benzinga · 02/11 13:10
  • ArTara Therapeutics Appoints Blaine Davis as Chief Financial Officer
  • GlobeNewswire · 02/11 13:00
  • ArTara Therapeutic Files For 5.78M Share Common Stock Offering By Selling Shareholders
  • Benzinga · 01/30 22:33
  • Benzinga's Top Upgrades, Downgrades For January 22, 2020
  • Benzinga · 01/22 14:51

Industry

Biotechnology & Medical Research
-0.13%
Pharmaceuticals & Medical Research
+5.97%

Hot Stocks

Symbol
Price
%Change
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%

About TARA

ArTara Therapeutics Inc., formerly Proteon Therapeutics Inc., is a clinical-stage company. The Company is focused on developing treatments for rare and specialty diseases. Its development programs focus on the treatment of rare diseases in structural and connective tissues, as well as rare hepatology/gastrointestinal and metabolic disorders. Its product pipeline includes TARA 002 and IV choline chloride for injection. TARA 002 is its lead program focused on the treatment of Lymphatic Malformations (LMs). TARA 002 is a cellular therapy based on OK-432, also known as Picibanil, which is derived from a genetically distinct strain of Streptococcus Pyogenes. IV choline chloride is an enzyme replacement therapy for patients with choline deficiency who exhibit symptoms of liver impairment. IV Choline Chloride is being developed for the treatment of Intestinal Failure Associated Liver Disease (IFALD).
More

Webull offers kinds of Artara Therapeutics Inc stock information, including NASDAQ:TARA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TARA stock news, and many more online research tools to help you make informed decisions.